Establishing Maintenance Doses Of IV Iron in Anemia Management To Improve Patient Outcomes

被引:0
作者
Nguyen, Timothy V. [1 ]
Wells, Debra [2 ]
机构
[1] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA
[2] Holy Name Hosp Reg Dialysis Ctr, Teaneck, NJ USA
关键词
CHRONIC KIDNEY-DISEASE; INTRAVENOUS IRON; HEMODIALYSIS-PATIENTS; ERYTHROPOIETIN; DIALYSIS;
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Iron deficiency is one of the most common findings in anemia management in patients on henzodialysis. Administration of intravenous iron therapy is important to maintain adequate serum ferritin and transferrin saturation levels for effective hemoglobin synthesis. This study investigates and presents the results of doses and frequencies of IV iron therapy.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 17 条
  • [1] Resolving the paradigm crisis in intravenous iron and erythropoietin management
    Besarab, A
    [J]. KIDNEY INTERNATIONAL, 2006, 69 : S13 - S18
  • [2] A study of parenteral iron regimens in hemodialysis patients
    Besarab, A
    Kaiser, JW
    Frinak, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) : 21 - 28
  • [3] Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465
  • [4] DANIEL WC, 2007, J AM SOC NEPHROL, V8, P975
  • [5] Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: An overview
    Dowling, Thomas C.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (13) : S3 - S7
  • [6] ESCHBACH JW, 1989, CONTRIB NEPHROL, V76, P160
  • [7] REDUCTION IN RECOMBINANT-HUMAN-ERYTHROPOIETIN DOSES BY THE USE OF CHRONIC INTRAVENOUS IRON SUPPLEMENTATION
    FISHBANE, S
    FREI, GL
    MAESAKA, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) : 41 - 46
  • [8] Intravenous Iron Versus Erythropoiesis-Stimulating Agents: Friends or Foes in Treating Chronic Kidney Disease Anemia?
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    Miller, Jessica E.
    Nissenson, Allen R.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (02) : 143 - 151
  • [9] Ferric gluconate reduces epoetion requirements in hemodialysis patients with elevated ferritin
    Kapoian, Toros
    O'Mara, Neeta B.
    Singh, Ajay K.
    Moran, John
    Rizkala, Adel R.
    Geronemus, Robert
    Kopelman, Robert C.
    Dahl, Naomi V.
    Coyne, Daniel W.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (02): : 372 - 379
  • [10] Ma JZ, 1999, J AM SOC NEPHROL, V10, P610